ALK-Positive Renal Cell Carcinoma in a Large Series of Consecutively Resected Korean Renal Cell Carcinoma Patients
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Recently, there have been a few reports of renal cell carcinoma (RCC) cases with anaplastic lymphoma kinase (ALK) gene fusion. In this study, we screened consecutively resected RCCs from a single institution for ALK protein expression by immunohistochemistry, and then we performed fluorescence in situ hybridization to confirm the ALK gene alteration in ALK immunohistochemistry-positive cases. Methods: We screened 829 RCCs by ALK immunohistochemistry, and performed fluorescence in situ hybridization analysis using ALK dual-color break-apart rearrangement probe. Histological review and additional immunohistochemistry analyses were done in positive cases. Results: One ALK-positive case was found. Initial diagnosis of this case was papillary RCC type 2. This comprises 0.12% of all RCCs (1/829) and 1.9% of papillary RCCs (1/53). This patient was a 44-year-old male with RCC found during routine health check-up. He was alive without evidence of disease 12 years after surgery. The tumor showed a papillary and tubular pattern, and showed positivity for CD10 (focal), epithelial membrane antigen, cytokeratin 7, pan-cytokeratin, PAX-2, and vimentin. Conclusions: We found the first RCC case with ALK gene rearrangement in Korean patients by ALK immunohistochemistry among 829 RCCs. This case showed similar histological and immunohistochemical features to those of previous adult cases with ALK rearrangement, and showed relatively good prognosis.
Abstract
Background: Recently, there have been a few reports of renal cell carcinoma (RCC) cases with anaplastic lymphoma kinase (ALK) gene fusion. In this study, we screened consecutively resected RCCs from a single institution for ALK protein expression by immunohistochemistry, and then we performed fluorescence in situ hybridization to confirm the ALK gene alteration in ALK immunohistochemistry-positive cases. Methods: We screened 829 RCCs by ALK immunohistochemistry, and performed fluorescence in situ hybridization analysis using ALK dual-color break-apart rearrangement probe. Histological review and additional immunohistochemistry analyses were done in positive cases. Results: One ALK-positive case was found. Initial diagnosis of this case was papillary RCC type 2. This comprises 0.12% of all RCCs (1/829) and 1.9% of papillary RCCs (1/53). This patient was a 44-year-old male with RCC found during routine health check-up. He was alive without evidence of disease 12 years after surgery. The tumor showed a papillary and tubular pattern, and showed positivity for CD10 (focal), epithelial membrane antigen, cytokeratin 7, pan-cytokeratin, PAX-2, and vimentin. Conclusions: We found the first RCC case with ALK gene rearrangement in Korean patients by ALK immunohistochemistry among 829 RCCs. This case showed similar histological and immunohistochemical features to those of previous adult cases with ALK rearrangement, and showed relatively good prognosis.
참고문헌 (24)
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival and Prevalence in 2010", Cancer Research and Treatment, 45(1), pp.1~14 (2013), 대한암학회
- Eble JN, "Pathology and genetics of tumours of the urinary system and male genital organs", pp.12~39 (2004), IARC Press
- Patard JJ, "Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience", J Clin Oncol, 23, pp.2763~2771 (2005)
- Singer EA, "Targeted therapeutic strategies for the management of renal cell carcinoma", Curr Opin Oncol, 24, pp.284~290 (2012)
- Morris SW, "Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin’s lymphoma", Science, 263, pp.1281~1284 (1994)
- Laurent C, "Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis", J Clin Oncol, 27, pp.4211~4216 (2009)
- Wang WY, "ALK-positive extramedullary plasmacytoma with expression of the CLTC-ALK fusion transcript", Pathol Res Pract, 207, pp.587~591 (2011)
- Cook JR, "Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study", Am J Surg Pathol, 25, pp.1364~1371 (2001)
- Chen Y, "Oncogenic mutations of ALK kinase in neuroblastoma", Nature, 455, pp.971~974 (2008)
- Kwak EL, "Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer", N Engl J Med, 363, pp.1693~1703 (2010)
- Butrynski JE, "Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor", N Engl J Med, 363, pp.1727~1733 (2010)
- Galkin AV, "Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK", Proc Natl Acad Sci U S A, 104, pp.270~275 (2007)
- Cerchietti L, "Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomas", PLoS One, 6, pp.e18436~ (2011)
- Azarova AM, "Emerging importance of ALK in neuroblastoma", Semin Cancer Biol, 21, pp.267~275 (2011)
- Kim H, "Detection of ALK gene rearrangement in non-small cell lung cancer: a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization with correlation of ALK protein expression", J Thorac Oncol, 6, pp.1359~1366 (2011)
- Paik JH, "Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: correlation with fluorescence in situ hybridization", J Thorac Oncol, 6, pp.466~472 (2011)
- Paik JH, "Clinicopathologic implication of ALK rearrangement in surgically resected lung cancer: a proposal of diagnostic algorithm for ALK-rearranged adenocarcinoma", Lung Cancer, 76, pp.403~409 (2012)
- Debelenko LV, "Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum", Mod Pathol, 24, pp.430~442 (2011)
- Mariño-Enríquez A, "ALK rearrangement in sickle cell trait-associated renal medullary carcinoma", Genes Chromosomes Cancer, 50, pp.146~153 (2011)
- Sukov WR, "ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients", Mod Pathol, 25, pp.1516~1525 (2012)
- Sugawara E, "Identification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method", Cancer, 118, pp.4427~4436 (2012)
- Kim SH, "Usefulness of a break-apart FISH assay in the diagnosis of Xp11.2 translocation renal cell carcinoma", Virchows Arch, 459, pp.299~306 (2011)
- Edge SB, "AJCC cancer staging manual" (2010), Springer
- Conklin CM, "Immunohistochemistry is a reliable screening tool for identification of ALK rearrangement in non-small-cell lung carcinoma and is antibody dependent", J Thorac Oncol, 8, pp.45~51 (2013)